Cover Image
市場調查報告書

免疫球蛋白產品的全球市場:2016∼2020年

Global Immunoglobulin Products Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 356738
出版日期 內容資訊 英文 84 Pages
訂單完成後即時交付
價格
Back to Top
免疫球蛋白產品的全球市場:2016∼2020年 Global Immunoglobulin Products Market 2016-2020
出版日期: 2016年04月13日 內容資訊: 英文 84 Pages
簡介

免疫球蛋白抗體是已知讓細菌和病毒等異物無力化的蛋白質。免疫球蛋白產品,1952年首次使用作免疫力缺乏的治療。現在免疫球蛋白治療用產品用於預防感染,以改善生活品質與延長壽命。全球免疫球蛋白產品市場,預計2016∼2020年,以年複合成長率6.84%擴大。

本報告提供全球免疫球蛋白產品市場現狀與至2020年的成長預測,市場趨勢與課題,各地區趨勢,主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 血漿產品:概要

  • 血漿的組成
  • 血漿產品的製造工程
  • 血漿臨床的使用
  • 血漿治療藥成本

第6章 血漿產品相關的法律規章

第7章 產品研發線

第8章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第9章 免疫球蛋白的各類型市場區隔

第10章 各用途市場市場區隔

  • 免疫力缺乏
  • 低伽馬球蛋白血症
  • CIDP
  • 先天性AIDS
  • CLL
  • 重症肌無力
  • MMN
  • ITP
  • 川崎病
  • Guillain-Barre症候群
  • 其他

第11章 各給藥途徑市場區隔

第12章 各出貨量市場區隔

第13章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第14章 推動市場的要素

第15章 促進要素的影響

第16章 市場課題

第17章 促進要素與課題的影響

第18章 市場趨勢

第19章 供應商環境

  • 競爭模式
  • 市場佔有率分析:2015年
  • CSL
  • Baxalta
  • Grifols
  • Octapharma
  • Kedrion
  • Biotest Pharmaceuticals
  • 其他值得注意的供應商

第20章 附錄

第21章 關於Technavio

圖表

目錄
Product Code: IRTNTR8965

About Immunoglobulin Products

Immunoglobulins, also known as antibodies, are proteins that help neutralize foreign objects such as bacteria and viruses. They help recognize and bind to particular antigens. Based on the difference in the amino acid sequence in the fragment crystallizable (Fc) region of the antibody heavy chain, they can be categorized into the following isotypes: IgA, IgD, IgE, IgG, and IgM. In 1952, immunoglobulin products were used for the first time to treat immune deficiency. They can be administered by either the intravenous (IV) or subcutaneous (SC) route. Immunoglobulin products given intravenously usually contain IgG. Immunoglobulin products are used to treat primary antibody deficiency, complex immune deficiency disorders, and life threatening infections. Immunoglobulin therapeutic products help prevent infections, improving the quality of life and increasing life expectancy.

Technavio's analysts forecast the global immunoglobulin products market to grow at a CAGR of 6.84% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global immunoglobulin products market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of immunoglobulin products used to treat various autoimmune and immunodeficiency diseases.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Immunoglobulin Products Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Baxalta
  • Biotest Pharmaceuticals Corp.
  • CSL Ltd.
  • Grifols SA
  • Kedrion SpA
  • Octapharma

Other Prominent Vendors

  • Abeona Therapeutics
  • Admabiologics
  • Anthera
  • Beijing Tiantan Biological Products (China)
  • Bharat Serums and Vaccines (India)
  • Bio Products Laboratory
  • China Biologic Products (China)
  • Emergent Biosolutions
  • Gliknik
  • Greencross
  • Hansamedical
  • Hualan Biological Engineering (China)
  • Immunomedics
  • Innate Pharma
  • Integrated Biotherapeutics
  • Janssen Pharmaceuticals
  • Kamada
  • LFB Group (France)
  • Mitsubishi Tanabe Pharma
  • Momenta Pharma
  • Patrys
  • Shanghai RAAS Blood Products (China)
  • Sichuan Yuanda Shuyang Pharmaceutical (China)
  • Sorrento Therapeutics

Market driver

  • Growing aging population
  • For a full, detailed list, view our report

Market challenge

  • High cost of therapy
  • For a full, detailed list, view our report

Market trend

  • Patient assistance programs
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings
  • Assumptions

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Plasma products: An overview

  • Components of blood plasma
  • Manufacturing process of plasma products
  • Clinical uses of plasma
  • Cost of plasma therapeutics

PART 06: Regulation of plasma products

PART 07: Pipeline portfolio

  • Information on few pipeline candidates

PART 08: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 09: Market segmentation by type of immunoglobulins

PART 10: Market segmentation by application

  • Immunodeficiency diseases
  • Hypogammaglobulinemia
  • CIDP
  • Congenital AIDS
  • CLL
  • Myasthenia gravis
  • MMN
  • ITP
  • Kawasaki disease
  • Guillain-Barre syndrome
  • Others

PART 11: Market segmentation by ROA

  • IVIG products
  • SCIG products
  • IMIG products

PART 12: Market segmentation by volume

  • Market overview
  • Immunoglobulin products market by volume in Americas
  • Immunoglobulin products market by volume in EMEA
  • Immunoglobulin products market by volume in APAC

PART 13: Geographical segmentation

  • Immunoglobulin products market in Americas
  • Immunoglobulin products market in EMEA
  • Immunoglobulin products market in APAC

PART 14: Market drivers

  • Growing older population
  • Increase in individuals with PID
  • Promising pipeline
  • Approval of immunoglobulins to treat neuroimmunological disorders
  • Rise in demand for IVIG therapies

PART 15: Impact of drivers

PART 16: Market challenges

  • High cost of therapy
  • Product recalls by US FDA
  • Limited plasma fractionation capacity
  • Post-transfusion adverse reactions
  • Stringent regulatory guidelines

PART 17: Impact of drivers and challenges

PART 18: Market trends

  • Patient assistance programs
  • Strategic alliances and M&A
  • Increased use of synthetic/recombinant products
  • Rise in awareness of PID

PART 19: Vendor landscape

  • Competitive scenario
  • Market share analysis 2015
  • CSL
  • Baxalta
  • Grifols
  • Octapharma
  • Kedrion
  • Biotest Pharmaceuticals
  • Other prominent vendors

PART 20: Appendix

  • List of abbreviations

PART 21: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Composition of blood
  • Exhibit 03: Composition of plasma
  • Exhibit 04: Total collection of plasma in US 2010-2014 (in liters)
  • Exhibit 05: Projected fractionation capacity of manufacturing units in US and EU (millions of liters/annum)
  • Exhibit 06: Process of procurement and manufacturing of plasma products
  • Exhibit 07: Regulatory policies of plasma protein therapy lifecycle
  • Exhibit 08: Pipeline molecules for immunoglobulin products
  • Exhibit 09: Pipeline share of immunoglobulin products 2015
  • Exhibit 10: Global immunoglobulin products market 2015-2020 ($ billions)
  • Exhibit 11: Five forces analysis
  • Exhibit 12: Global immunoglobulin products market segment by type of immunoglobulins
  • Exhibit 13: Global immunoglobulin products market share by type of immunoglobulins 2015
  • Exhibit 14: Global immunoglobulin products market segmentation by application
  • Exhibit 15: Global immunoglobulin products market share by application
  • Exhibit 16: Global immunoglobulin products market segment by ROA
  • Exhibit 17: Global immunoglobulin products market share by ROA2015
  • Exhibit 18: Global IVIG products market 2015-2020 ($ billions)
  • Exhibit 19: Global SCIG products market 2015-2020 ($ billions)
  • Exhibit 20: Global IMIG products market 2015-2020 ($ billions)
  • Exhibit 21: Global immunoglobulin products market revenue by ROA 2015-2020 ($ billions)
  • Exhibit 22: Global immunoglobulin products market YoY revenue and growth based on ROA 2015-2020 ($ billions)
  • Exhibit 23: Global immunoglobulin products market by volume 2015
  • Exhibit 24: Global immunoglobulin products by volume 2015 and 2020 (tons)
  • Exhibit 25: Global immunoglobulin products market by volume 2015-2020 (tons)
  • Exhibit 26: Average immunoglobulin consumption by country (Kilograms per million people) 2012
  • Exhibit 27: Immunoglobulin products market in Americas by volume 2015-2020 (tons)
  • Exhibit 28: Global immunoglobulin products market by volume 2015-2020 (tons)
  • Exhibit 29: Immunoglobulin products market in EMEA by volume 2015-2020 (tons)
  • Exhibit 30: Global immunoglobulin products market by geography 2015
  • Exhibit 31: Global immunoglobulin products market revenue by geography 2015-2020 ($ billions)
  • Exhibit 32: Immunoglobulin products market in Americas 2015-2020 ($ billions)
  • Exhibit 33: Immunoglobulin products market in EMEA 2015-2020 ($ billions)
  • Exhibit 34: Immunoglobulin products market in APAC 2015-2020 ($ billions)
  • Exhibit 35: Global immunoglobulin products market YoY revenue and growth based on geography 2015-2020
  • Exhibit 36: Population aged 60 years and over: World, developed, and developing regions (millions)
  • Exhibit 37: Impact of drivers
  • Exhibit 38: Impact of drivers and challenges
  • Exhibit 39: Global immunoglobulin products market share analysis 2015
  • Exhibit 40: Market share analysis of top vendors 2015
  • Exhibit 41: CSL: Immunoglobulins products segmentation
  • Exhibit 42: Key takeaways
  • Exhibit 43: Baxalta: Product categories by revenue 2015
  • Exhibit 44: Baxalta: YoY revenue comparison of immunoglobulin therapy area 2014 and 2015
  • Exhibit 45: Baxalta: Geographic segmentation of immunoglobulin therapies by revenue 2015
  • Exhibit 46: CSL: Key takeaways
  • Exhibit 47: Grifols: YoY growth rate and revenue of bioscience segment 2013-2015 ($ billions)
  • Exhibit 48: Grifols: Key takeaways
  • Exhibit 49: Octapharma: Key takeaways
  • Exhibit 50: Kedrion: Key takeaways
  • Exhibit 51: Biotest: Key takeaways
Back to Top